Logo image of CSAI

CLOUDASTRUCTURE INC-A (CSAI) Stock Fundamental Analysis

NASDAQ:CSAI - Nasdaq - US18912E2072 - Common Stock - Currency: USD

6.68  +0.44 (+7.05%)

After market: 6.6 -0.08 (-1.2%)

Fundamental Rating

2

Overall CSAI gets a fundamental rating of 2 out of 10. We evaluated CSAI against 81 industry peers in the IT Services industry. CSAI has a great financial health rating, but its profitability evaluates not so good. CSAI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CSAI had negative earnings in the past year.
CSAI Yearly Net Income VS EBIT VS OCF VS FCFCSAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of CSAI (-907.05%) is worse than 97.53% of its industry peers.
Looking at the Return On Equity, with a value of -1992.70%, CSAI is doing worse than 86.42% of the companies in the same industry.
Industry RankSector Rank
ROA -907.05%
ROE -1992.7%
ROIC N/A
ROA(3y)-113.17%
ROA(5y)N/A
ROE(3y)-121.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSAI Yearly ROA, ROE, ROICCSAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CSAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSAI Yearly Profit, Operating, Gross MarginsCSAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -500 -1K -1.5K -2K

More info and screens

7

2. Health

2.1 Basic Checks

CSAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CSAI has about the same amount of shares outstanding.
CSAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CSAI Yearly Shares OutstandingCSAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M
CSAI Yearly Total Debt VS Total AssetsCSAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M

2.2 Solvency

CSAI has an Altman-Z score of 29.20. This indicates that CSAI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 29.20, CSAI belongs to the top of the industry, outperforming 97.53% of the companies in the same industry.
CSAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 29.2
ROIC/WACCN/A
WACC10.14%
CSAI Yearly LT Debt VS Equity VS FCFCSAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 5M -5M 10M -10M

2.3 Liquidity

CSAI has a Current Ratio of 1.67. This is a normal value and indicates that CSAI is financially healthy and should not expect problems in meeting its short term obligations.
CSAI has a Current ratio of 1.67. This is comparable to the rest of the industry: CSAI outperforms 55.56% of its industry peers.
A Quick Ratio of 1.24 indicates that CSAI should not have too much problems paying its short term obligations.
The Quick ratio of CSAI (1.24) is worse than 64.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.24
CSAI Yearly Current Assets VS Current LiabilitesCSAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M

More info and screens

1

3. Growth

3.1 Past

CSAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.53%, which is quite impressive.
Looking at the last year, CSAI shows a very strong growth in Revenue. The Revenue has grown by 24.13%.
EPS 1Y (TTM)22.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)24.13%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CSAI Yearly Revenue VS EstimatesCSAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 200K 400K 600K
CSAI Yearly EPS VS EstimatesCSAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CSAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSAI Price Earnings VS Forward Price EarningsCSAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSAI Per share dataCSAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CSAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLOUDASTRUCTURE INC-A

NASDAQ:CSAI (3/7/2025, 8:16:20 PM)

After market: 6.6 -0.08 (-1.2%)

6.68

+0.44 (+7.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner Change0%
Market Cap97.46M
AnalystsN/A
Price TargetN/A
Short Float %0.52%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 160.56
P/FCF N/A
P/OCF N/A
P/B 215.62
P/tB 215.62
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -907.05%
ROE -1992.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-113.17%
ROA(5y)N/A
ROE(3y)-121.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.24
Altman-Z 29.2
F-ScoreN/A
WACC10.14%
ROIC/WACCN/A
Cap/Depr(3y)644.22%
Cap/Depr(5y)N/A
Cap/Sales(3y)152.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.13%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.66%
OCF growth 3YN/A
OCF growth 5YN/A